38LOW

PGC

PARAGON FPO [PGC]
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, breast milk tracking, electrodes; sterilisable transducers designed for surgical procedures, digital theatre integration, infection control, infusion therapy, temperature management, enteral feeding, pain management, lasers, operating room products, surgical consumables, and ultrasound systems. In addition, the company offers aesthetic devices for dermatologists, cosmetic surgeons, general practitioners, beauty and aesthetic providers, and educational institutions; natural, traditional, and complementary health products and services; critical care and dental solutions; urology solutions, such as shockwave therapy, lasers, and accessories for infection control; medical products and consumables; and orthopaedics solutions, including hip and knee arthroplasty, upper and lower extremity, sports medicine, reverse shoulder replacement, and powered surgical tools. Further, it offers medical equipment repair, maintenance, and support services; technology and communication solutions, such as telephony, nurse call, access control, cctv, cordless, and Wi-Fi; supplies medical equipment to veterans, war widows, and families; and veterinary products. Additionally, it is involved in maintenance of technical medical equipment to the health, aged care, and veterinary markets; and distribution of pharmaceuticals, medical consumables, and complementary medicines to Australian healthcare market. The company is based in Mount Waverley, Australia.
Healthcare · ASX Small Cap
$0.2100 +2.4%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical53
Catalyst50
Sentiment50
Fundamental87
Momentum28
Risk Gate50
Get alerts when PGC's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track PGC — Free

Active Signals

Bullish Signals

  • MACD momentum is picking up steam
  • Pressing against the upper Bollinger Band — extended and may need to cool off
  • Volume surging at 3.4x normal while price falls — heavy selling pressure
  • Knocking on the door of resistance — if it punches through, things could get interesting
  • On a tear — up 20.0% over the last 5 days
  • Beating the Small Ords index — relative strength of 1.23, so it's outpacing the pack
  • Cash positive / operating cashflow positive
  • Low P/S ratio (0.1x)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (13% of range)
  • CANSLIM S: Tight float (30%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 52% over the past year
  • Beneish M-Score 7.68 > -1.78: likely earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • Stochastic is stretched into overbought — could need a breather
  • Below the 200-day average — the long-term trend is still working against it
  • Negative profit margins (-0%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-1.35%/day)
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about PGC
"What's driving PGC's score?" "How does PGC compare to peers?" "Key risks for PGC?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

LOW 1H26 Investor Presentation
NONE 1H26 Results Release
NONE 1H26 Appendix 4D and Half Year Report
NONE Appointment of Managing Director

Recent ASX Announcements

2026-02-24 1H26 Investor Presentation PRICE SENSITIVE
2026-02-24 1H26 Results Release PRICE SENSITIVE
2026-02-24 1H26 Appendix 4D and Half Year Report PRICE SENSITIVE
2026-02-24 Appointment of Managing Director PRICE SENSITIVE
2026-02-24 1H26 Results Briefing

Key Metrics

$342.6M
Market Cap
489K
Avg Volume
3.4x
Vol Ratio
$0.17 — $0.45
52-Week Range
0.1%
Short Interest
N/A
Cash Runway
-4.5%
ROE
-0.4%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsneutralCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 30%
LLeader vs LaggardlaggardRS: -0
IInstitutional SponsorshipweakInst: 8%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #95 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:PGC vs ATXPGC vs PNVPGC vs IMM
Scout Pro — Deeper Analysis for PGC
Try Pro free for 30 days
Share this analysis

Track PGC and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required